BTIM will launch 7 new human embryonic progenitor cell lines and 7 novel culture media for these lines on 9/1/10. Read more…
BTIM’s five (5) new human stem cell lines are now offered for research use only. These highly purified, novel, and scalable cell lines are embryonic progenitors, meaning that they are intermediate between human embryonic stem cells and fully developed cells. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.